News | October 30, 2025
Allergan Aesthetics and Girls inspire the next generation of women leaders in STEM
Allergan Aesthetics reaffirms commitment to empowering girls through STEM mentorship and education initiatives
Allergan Aesthetics reaffirms commitment to empowering girls through STEM mentorship and education initiatives
Advancing toward Phase 2a evaluation in chemotherapy-related pain, a condition with no approved treatments and potential for FDA Fast Track designation
Medherant’s testosterone TEPI Patch could become the first-in-class testosterone patch developed specifically for women
Arora brings over 30 years of experience in the pharmaceutical and healthcare industry
It will produce a comprehensive range of dosage forms including tablets, hard gelatin capsules, liquids, injectables, topicals, and beta-lactam products
Bioconjugation capability to complement commercial payload, linker, and monoclonal antibody services
Global Phase 3 MANEUVER study highlights ongoing benefits and consistent safety profile
The initial $100 million will fund a state-of-the-art hard-shell capsule facility in Atlanta
Gazyva/Gazyvaro is the only anti-CD20 monoclonal antibody to demonstrate a complete renal response benefit in lupus nephritis in a randomised phase III study
The combination is approved for advanced endometrial carcinoma that is pMMR or not MSI-H and has progressed after prior systemic therapy
Subscribe To Our Newsletter & Stay Updated
